| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,501 |
23,511 |
$2.35M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,221 |
19,605 |
$1.32M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,800 |
11,358 |
$1.16M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,658 |
10,948 |
$1.11M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,445 |
21,562 |
$1.07M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,995 |
8,614 |
$959K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19,934 |
18,237 |
$745K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,674 |
7,353 |
$686K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21,205 |
20,245 |
$296K |
| 99051 |
|
12,085 |
11,298 |
$209K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,517 |
6,758 |
$193K |
| 99215 |
Prolong outpt/office vis |
1,090 |
1,011 |
$137K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,146 |
2,987 |
$111K |
| 97802 |
|
24,684 |
23,528 |
$105K |
| 92588 |
|
5,900 |
5,549 |
$101K |
| 99188 |
|
6,010 |
5,663 |
$94K |
| 96127 |
|
12,079 |
11,513 |
$79K |
| 86769 |
|
1,611 |
833 |
$78K |
| 99408 |
|
9,339 |
8,750 |
$69K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,452 |
6,017 |
$63K |
| 99050 |
|
3,042 |
2,709 |
$62K |
| 99429 |
|
6,845 |
5,026 |
$58K |
| 99381 |
|
625 |
501 |
$45K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,881 |
1,850 |
$42K |
| 99406 |
|
8,569 |
7,998 |
$28K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
25,957 |
24,470 |
$24K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,186 |
2,116 |
$23K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
210 |
196 |
$21K |
| 99173 |
|
12,505 |
11,507 |
$18K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,026 |
1,956 |
$18K |
| 96161 |
|
6,306 |
5,200 |
$16K |
| 85018 |
|
5,287 |
4,984 |
$14K |
| 81003 |
|
3,438 |
3,202 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
492 |
438 |
$7K |
| 85027 |
|
932 |
844 |
$7K |
| 99383 |
|
68 |
65 |
$7K |
| 90461 |
|
817 |
635 |
$6K |
| 83655 |
|
815 |
741 |
$5K |
| 90619 |
|
1,252 |
1,168 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
183 |
164 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
77 |
72 |
$3K |
| 87110 |
|
244 |
217 |
$3K |
| 99384 |
|
30 |
28 |
$3K |
| 81025 |
|
294 |
289 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
154 |
134 |
$2K |
| 31720 |
|
26 |
20 |
$2K |
| 90670 |
|
8,532 |
7,300 |
$1K |
| 90651 |
|
2,917 |
2,751 |
$1K |
| 99382 |
|
13 |
13 |
$1K |
| 90716 |
|
3,569 |
3,314 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
63 |
53 |
$958.51 |
| 94010 |
|
43 |
39 |
$957.99 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
37 |
35 |
$914.28 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
12 |
$788.88 |
| 90686 |
|
3,823 |
3,662 |
$706.98 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
60 |
48 |
$599.40 |
| 90707 |
|
3,780 |
3,488 |
$433.76 |
| 90633 |
|
4,077 |
3,721 |
$263.60 |
| 90620 |
|
740 |
714 |
$200.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
35 |
35 |
$130.62 |
| 36416 |
|
697 |
674 |
$93.93 |
| 90715 |
|
1,436 |
1,350 |
$62.41 |
| 90734 |
|
2,024 |
1,917 |
$50.00 |
| 90696 |
|
1,266 |
1,179 |
$37.50 |
| 90656 |
|
330 |
319 |
$22.35 |
| 90700 |
|
1,042 |
965 |
$0.00 |
| 90681 |
|
3,321 |
2,661 |
$0.00 |
| 90647 |
|
6,587 |
5,511 |
$0.00 |
| 90723 |
|
6,406 |
5,321 |
$0.00 |